RA CAPITAL MANAGEMENT, L.P. Diversified Active

CIK: 0001346824 · Show all filings

Period: Q3 2013 (← Previous) (Next →)

Filing Date: Nov 14, 2013

Total Value ($000): $958,088 (100.0% shares, 0.0% debt)

Holdings (39)

ACAD ACADIA PHARMACEUTICALS INC 15.1%
Value ($000) $144,218 Shares 5,250,000 Est. Cost $13.77 Unrealized +51.8%
DYAX CORP 7.5%
Value ($000) $71,470 Shares 10,418,379 Est. Cost $3.46 Unrealized
NOVAVAX INC 6.8%
Value ($000) $65,520 Shares 20,800,000 Est. Cost $2.24 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.8%
Value ($000) $55,915 Shares 2,035,510 Est. Cost $13.77 Unrealized +51.8%
THERAPEUTICSMD INC 5.1%
Value ($000) $48,429 Shares 16,528,641 Est. Cost $3.00 Unrealized
INSM INSMED INC 4.9%
Value ($000) $46,570 Shares 2,983,319 Est. Cost $10.68 Unrealized +18.9%
SGMO SANGAMO BIOSCIENCES INC 4.7%
Value ($000) $44,669 Shares 4,258,244 Est. Cost $8.72 Unrealized +13.8%
ACHILLION PHARMACEUTICALS IN 4.6%
Value ($000) $43,660 Shares 14,457,061 Est. Cost $5.68 Unrealized
BCRX BIOCRYST PHARMACEUTICALS 4.4%
Value ($000) $42,549 Shares 5,844,700 Est. Cost $5.07 Unrealized 0.0%
NEWLINK GENETICS CORP 3.6%
Value ($000) $34,561 Shares 1,840,294 Est. Cost $19.72 Unrealized
PRTA PROTHENA CORP PLC 3.5%
Value ($000) $33,307 Shares 1,646,399 Est. Cost $15.16 Unrealized +16.7%
SGMO SANGAMO BIOSCIENCES INC 3.3%
Value ($000) $31,470 Shares 3,000,000 Est. Cost $8.72 Unrealized +13.8%
XOMA CORP DEL 3.2%
Value ($000) $31,051 Shares 6,915,525 Est. Cost $3.66 Unrealized
DERMA SCIENCES INC 2.6%
Value ($000) $24,697 Shares 1,994,876 Est. Cost $13.35 Unrealized
SUNESIS PHARMACEUTICALS INC 2.5%
Value ($000) $24,152 Shares 4,869,261 Est. Cost $5.18 Unrealized
KERYX BIOPHARMACEUTICALS INC 2.5%
Value ($000) $24,128 Shares 2,391,261 Est. Cost $7.47 Unrealized
HYPERION THERAPEUTICS INC 2.5%
Value ($000) $23,592 Shares 902,858 Est. Cost $22.00 Unrealized
CHEMOCENTRYX INC 1.8%
Value ($000) $16,932 Shares 3,045,380 Est. Cost $5.56 Unrealized
ACHILLION PHARMACEUTICALS IN 1.7%
Value ($000) $16,610 Shares 5,500,000 Est. Cost $5.68 Unrealized
BLUEBIRD BIO INC 1.3%
Value ($000) $12,602 Shares 467,418 Est. Cost $26.96 Unrealized
ROCKWELL MED INC 1.2%
Value ($000) $11,400 Shares 1,000,000 Est. Cost Unrealized
MYGN MYRIAD GENETICS INC 1.1%
Value ($000) $10,575 Shares 450,000 Est. Cost $28.41 Unrealized 0.0%
OMER OMEROS CORP 1.1%
Value ($000) $10,289 Shares 1,055,311 Est. Cost $4.61 Unrealized +29.3%
KERYX BIOPHARMACEUTICALS INC 1.1%
Value ($000) $10,090 Shares 1,000,000 Est. Cost $7.47 Unrealized
AMPIO PHARMACEUTICALS INC 1.0%
Value ($000) $9,942 Shares 1,325,566 Est. Cost $7.50 Unrealized
NEWLINK GENETICS CORP 1.0%
Value ($000) $9,390 Shares 500,000 Est. Cost $19.72 Unrealized
ENZO BIOCHEM INC 0.9%
Value ($000) $8,437 Shares 3,348,029 Est. Cost $2.08 Unrealized
MIRATI THERAPEUTICS INC 0.9%
Value ($000) $8,359 Shares 551,723 Est. Cost $15.15 Unrealized
DYNAVAX TECHNOLOGIES CORP 0.7%
Value ($000) $7,140 Shares 6,000,000 Est. Cost $1.10 Unrealized
ONCOGENEX PHARMACEUTICALS IN 0.7%
Value ($000) $7,076 Shares 763,332 Est. Cost $9.80 Unrealized
CORONADO BIOSCIENCES INC 0.7%
Value ($000) $7,011 Shares 1,000,000 Est. Cost Unrealized
PTCT PTC THERAPEUTICS INC 0.7%
Value ($000) $6,438 Shares 300,000 Est. Cost $17.38 Unrealized 0.0%
ARROWHEAD RESH CORP 0.5%
Value ($000) $5,005 Shares 879,561 Est. Cost $2.00 Unrealized
DYAX CORP 0.4%
Value ($000) $3,430 Shares 500,000 Est. Cost $3.46 Unrealized
TGTX TG THERAPEUTICS INC 0.3%
Value ($000) $3,024 Shares 600,000 Est. Cost $6.12 Unrealized 0.0%
AGIO AGIOS PHARMACEUTICALS INC 0.2%
Value ($000) $1,957 Shares 70,000 Est. Cost $27.61 Unrealized 0.0%
OCERA THERAPEUTICS INC 0.2%
Value ($000) $1,830 Shares 215,999 Est. Cost $8.47 Unrealized
EPIZYME INC 0.0%
Value ($000) $400 Shares 10,000 Est. Cost $28.13 Unrealized
SAVIENT PHARMACEUTICALS INC 0.0%
Value ($000) $193 Shares 1,000,000 Est. Cost $0.23 Unrealized